Canine Leptospirosis: Serovars, Clinical Presentation, and Diagnostic Testing

Introduction

Canine leptospirosis is a globally distributed zoonotic disease caused by pathogenic spirochetes of the genus Leptospira. In dogs, infection often results in acute febrile illness with variable renal and hepatic involvement, and progression to life-threatening conditions such as acute kidney injury (AKI) and pulmonary hemorrhage syndrome [1, 2]. The disease is maintained in nature through chronic renal carriage in reservoir hosts, primarily wild and domestic mammals, from which leptospires are shed in urine [3]. Dogs serve both as incidental hosts and as potential reservoir hosts for certain serovars, notably Leptospira interrogans serovar Canicola [4].

This article provides a detailed examination of the relevant serovars affecting dogs, the spectrum of clinical presentation, and the principles of diagnostic testing including the microscopic agglutination test (MAT), quantitative PCR (qPCR), culture, and serological methods. The interpretation of test results in the context of vaccination history and disease stage is emphasized.

Etiology and Serovars

Leptospira species are gram-negative, obligate aerobic spirochetes of the family Leptospiraceae. Pathogenic members are classified by serovar based on lipopolysaccharide (LPS) antigens, with over 250 recognized serovars grouped into genomospecies such as L. interrogans, L. kirschneri, and L. borgpetersenii [5, 6]. In dogs, the most commonly identified serovars include:

• L. interrogans serovar Canicola
• L. interrogans serovar Icterohaemorrhagiae
• L. kirschneri serovar Grippotyphosa
• L. interrogans serovar Pomona
• L. borgpetersenii serovar Hardjo (rare in dogs but reported) [7, 8]

Table 1 summarizes the serovars, their typical reservoir hosts, and clinical phenotypes.

Table 1. Common Canine Leptospira Serovars and Reservoir Hosts

Serovar distribution varies geographically and temporally [9, 10]. Canicola was historically the most common canine serovar but has declined in prevalence due to widespread vaccination. In many regions, Icterohaemorrhagiae and Grippotyphosa now predominate [11, 12]. Mixed serovar exposures are common due to overlapping ecologies.

Clinical Presentation

The incubation period in dogs ranges from 2 to 20 days, depending on the infectious dose, serovar, and host immune status [13]. Clinical signs are highly variable, ranging from subclinical infection to peracute death.

Acute Phases and Organ Tropism

Leptospires penetrate mucous membranes or abraded skin and rapidly disseminate through the bloodstream (leptospiremic phase), lasting 4 to 10 days [14]. During this phase, fever (39.5 to 41 degrees Celsius), myalgia, shivering, and reluctance to move are common. As the immune response develops, leptospires are cleared from blood but persist in immune-privileged sites including the renal tubules, liver, and eyes [15].

Renal Manifestations

Renal involvement is a hallmark of canine leptospirosis. Tubulointerstitial nephritis leads to polyuria, polydipsia, isosthenuria, and azotemia [16, 17]. Acute kidney injury (AKI) can progress to oliguric or anuric renal failure. Renal tubular damage results in enzymuria (elevated gamma-glutamyl transferase, alkaline phosphatase, and N-acetyl-beta-D-glucosaminidase) [18]. Urinalysis typically reveals proteinuria, glucosuria (tubular proteinuria and glycosuria), and granular casts.

Hepatic Manifestations

Hepatic involvement ranges from mild elevations of liver enzymes (alanine aminotransferase, aspartate aminotransferase) to marked icterus and cholestasis. Hyperbilirubinemia is most commonly associated with serovar Icterohaemorrhagiae [19]. Coagulopathy secondary to hepatic insufficiency or disseminated intravascular coagulation may occur [20].

Pulmonary Hemorrhage Syndrome

A severe form of leptospirosis characterized by pulmonary hemorrhage has been increasingly recognized in dogs, primarily associated with serovar Icterohaemorrhagiae [21, 22]. Affected dogs present with dyspnea, coughing, hemoptysis, and acute respiratory distress. Radiographic findings include diffuse interstitial to alveolar infiltrates. The pathogenesis involves endothelial damage and immune-mediated vasculitis [23].

Other Clinical Findings

Ocular manifestations include anterior uveitis, which may develop during the convalescent phase. Myocarditis, pancreatitis, and neurological signs (seizures, stupor) are less common but documented [24].

Laboratory Abnormalities

Complete blood count abnormalities include thrombocytopenia (common), leukocytosis with left shift, and mild anemia. Serum biochemistry reveals azotemia, hyperphosphatemia, elevated liver enzymes, hyperbilirubinemia, and electrolyte disturbances (hyponatremia, hypokalemia). Coagulation times (prothrombin time, activated partial thromboplastin time) may be prolonged [25].

Differential Diagnoses

The differential diagnosis list includes Canine Parvovirus enteritis (especially in young dogs), Canine Coronavirus enteritis, Canine Distemper Virus neurologic disease, immune-mediated hemolytic anemia, hepatotoxins, and other causes of AKI (e.g., ethylene glycol toxicity). The overlap in clinical signs underscores the importance of specific diagnostic testing.

Diagnostic Testing

Definitive diagnosis of canine leptospirosis relies on demonstration of the organism, its DNA, or specific antibody responses. A combination of tests is often required due to limitations of each method.

Darkfield Microscopy and Culture

Direct visualization of leptospires in urine or blood using darkfield microscopy is rapid but lacks sensitivity and specificity; artifacts (e.g., fibrin strands, cellular debris) cause false positives [26]. Culture of leptospires from blood (first week of illness), urine (after first week), or tissues is the historical gold standard but requires specialized media (e.g., Ellinghausen-McCullough-Johnson-Harris (EMJH) medium) and prolonged incubation (up to 8 to 16 weeks) [27]. Culture sensitivity is low (20 to 40 percent) and impractical for clinical decision-making.

Microscopic Agglutination Test (MAT)

The MAT is the reference serological test for leptospirosis diagnosis [28]. It measures agglutinating antibodies (predominantly IgM) against a panel of live or killed Leptospira serovars. Titers are expressed as the reciprocal of the highest serum dilution showing 50 percent agglutination.

Interpretation Guidelines:

• A single titer of 1:800 or higher in a dog with compatible clinical signs is considered evidence of current or recent infection, provided vaccination history is considered [29].
• Paired acute and convalescent sera (collected 2 to 4 weeks apart) demonstrating a fourfold or greater rise in titer confirms active infection.
• Vaccinated dogs may have low (1:100 to 1:400) titers against vaccine serovars (typically Canicola and Icterohaemorrhagiae), but these titers rarely exceed 1:800 and decline over months [30, 31].
• Serovars not included in the vaccine panel (e.g., Grippotyphosa, Pomona) are more likely to represent natural exposure.

Limitations of MAT:

• Cross-reactivity between serovars makes infecting serovar identification unreliable [32].
• Antibody titers may take 5 to 10 days to rise, resulting in false negatives early in infection.
• Previous vaccination can obscure interpretation.
• The test requires a panel of live leptospires, specialized facilities, and subjective reading by microscopy [33].

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISA methods detect genus-specific antibodies (e.g., IgM, IgG) using whole-cell lysate or recombinant antigens such as LipL32, an outer membrane lipoprotein [34, 35]. ELISAs are faster than MAT and can differentiate IgM (current infection) from IgG (past exposure or vaccination). Commercial ELISA kits are available but sensitivity and specificity vary. ELISA results should be confirmed by MAT or PCR [36]. For further details on this assay platform, see the article on Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus (p27 antigen detection principles apply broadly).

Polymerase Chain Reaction (PCR)

Real-time quantitative PCR (qPCR) targeting conserved genes such as lipL32, secY, or 16S rRNA is now a mainstay for early diagnosis [37, 38]. PCR detects leptospiral DNA in blood (first 7 to 10 days of illness) and urine (from day 7 onward). Because PCR detects live and dead organisms, a positive result indicates active leptospiremia or leptospiruria, not merely prior exposure.

Advantages of PCR:

• High sensitivity (90 to 100 percent in blood during acute phase) and specificity (approaching 100 percent) [39].
• Rapid turnaround time (hours) compared to MAT and culture.
• Independent of antibody production and vaccination status.

Limitations of PCR:

• Detection window in blood is narrow; after the first week, bacteremia wanes and blood PCR may become negative while urine PCR remains positive.
• Urine PCR can remain positive for weeks after clinical resolution, complicating interpretation of cure [40].
• Inhibitors in urine (e.g., high urea, low pH) may cause false negatives if not addressed [41].
• Multiplex PCR panels can also detect other pathogens, such as Bartonella or Anaplasma, which may be relevant in tick-borne co-infections (see Anaplasma phagocytophilum in Livestock and Companion Animals).

Diagnostic Workflow

A decision tree for diagnosing canine leptospirosis is presented in Figure 1 below.

Figure 1. Diagnostic Algorithm for Suspected Canine Leptospirosis

flowchart TD
    A[Clinical suspicion: fever, AKI, icterus, respiratory signs], > B{Collect blood and urine}
    B, > C[Perform qPCR on blood and urine]
    B, > D[Perform MAT on acute serum]
    C, > E{Result: Positive?}
    E, > |Yes| F[Leptospiremia/leptospiruria confirmed]
    E, > |No| G[Consider early infection or cleared DNA]
    D, > H{Titer >= 1:800 or 4-fold rise on paired samples?}
    H, > |Yes| I[Serological evidence of infection]
    H, > |No| J[Repeat serology in 2-4 weeks]
    J, > K[Fourfold rise?]
    K, > |Yes| L[Confirmed]
    K, > |No| M[Alternative diagnosis or prior vaccination]
    I, > N[Integrate PCR and serology: if both positive, definite; if PCR pos/ serology neg, treat; if PCR neg/ serology pos, consider late presentation]

Interpretation of Combined Testing

The optimal diagnostic approach combines qPCR with MAT [42]. Cases that are PCR-positive and MAT-negative indicate very early infection (<7 days). Cases that are PCR-negative and MAT-positive indicate infection beyond the leptospiremic phase or prior vaccination. Cases that are positive by both methods provide the strongest evidence of active infection requiring treatment.

Other Laboratory Aids

Supportive laboratory findings include thrombocytopenia, elevated creatine kinase, and renal biomarkers such as symmetric dimethylarginine (SDMA) and urinary enzyme activities [43]. Point-of-care lactate and blood gas analyzers can aid in triaging the severity of metabolic acidosis (see Point-of-Care Lactate and Blood Gas Analyzers in Canine Emergency Triage).

Clinical Interpretation Challenges

Vaccination Interference

Vaccination stimulates MAT titers, most often against Canicola and Icterohaemorrhagiae, which can persist for months. Dogs that have been recently vaccinated (within 3 months) may have titers of 1:400 to 1:800, which can be misinterpreted as active infection [44]. In contrast, PCR remains negative unless the dog is truly infected.

Chronic Carrier State

A small proportion of dogs become chronic renal carriers and shed leptospires in urine for months to years without clinical signs [45]. Urine PCR is positive, but MAT may be low or negative. Such dogs represent a zoonotic risk.

Cross-Reactivity in Serology

The MAT panel should include locally prevalent serovars to avoid missing infections. Cross-reactions between serovars such as Grippotyphosa and Pomona are common, and the highest titer serovar may not be the infecting one [46].

Treatment and Prognosis

Antimicrobial therapy is indicated in all confirmed cases. Doxycycline (5 mg/kg PO q12h) is the drug of choice for both acute treatment and elimination of the renal carrier state [47]. Penicillin derivatives (e.g., potassium penicillin G) can be used for initial therapy in severe cases to avoid gastric irritation, but they do not clear the carrier state [48]. Supportive care including fluid therapy, antiemetics, and hemodialysis for severe AKI is often required [49].

Prognosis depends on the severity of organ dysfunction. Mortality rates in published studies range from 5 to 25 percent, with pulmonary hemorrhage carrying the highest fatality risk [50].

Conclusion

Canine leptospirosis remains a diagnostic challenge due to its variable clinical signs and the limitations of each test modality. The MAT, despite its shortcomings, remains the serological reference method, while qPCR provides rapid, species-specific detection of active infection. A combined testing strategy improves diagnostic accuracy and guides appropriate antimicrobial therapy. Serovar identification is important for epidemiological surveillance and for informing vaccination protocols, though current vaccines do not cover all serovars. The zoonotic potential of leptospirosis necessitates prompt diagnosis and biosecurity measures in veterinary practice.

References

[1] Prescott JF, McEwen B, Abrams-Ogg A, et al. (2009) Leptospirosis in dogs: a review. Can Vet J 50(8): 819-826.

[2] Greene CE, Sykes JE. (2012) Leptospirosis. In: Infectious Diseases of the Dog and Cat, 4th ed. Elsevier: 431-447.

[3] Ellis WA. (2015) Animal leptospirosis. Curr Top Microbiol Immunol 387: 99-137.

[4] Sykes JE, Hartmann K, Lunn KF, et al. (2011) 2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention. J Vet Intern Med 25(1): 1-13.

[5] Levett PN. (2001) Leptospirosis. Clin Microbiol Rev 14(2): 296-326.

[6] Bharti AR, Nally JE, Ricaldi JN, et al. (2003) Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3(12): 757-771.

[7] Goldstein RE. (2010) Canine leptospirosis. Vet Clin North Am Small Anim Pract 40(6): 1091-1101.

[8] Koizumi N, Muto M, Yamamoto S, et al. (2020) Seroprevalence of Leptospira spp. in dogs in Japan. J Vet Med Sci 82(2): 220-225.

[9] Ward MP, Guptill LF, Wu CC. (2004) Evaluation of environmental risk factors for leptospirosis in dogs: a spatial analysis. Vet Rec 155(20): 633-638.

[10] Alston JM, Broom JC. (1958) Leptospirosis in Man and Animals. E&S Livingstone.

[11] Ghneim GS, Viers JH, Chomel BB, et al. (2007) Use of a case-control study and geographic information systems to determine environmental and demographic risk factors for canine leptospirosis. Vet Res 38(1): 37-50.

[12] Hartskeerl RA, Collares-Pereira M, Ellis WA. (2011) Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect 17(4): 494-501.

[13] Faine S, Adler B, Bolin C, Perolat P. (1999) Leptospira and Leptospirosis, 2nd ed. MediSci.

[14] Segers RP, van der Drift JA, de Nijs AM, et al. (1990) Molecular analysis of a sphingomyelinase C gene from Leptospira interrogans serovar hardjo. Infect Immun 58(9): 2850-2855.

[15] Ko AI, Goarant C, Picardeau M. (2009) Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol 7(10): 736-747.

[16] Maggi RS, Krafft E, La Placa G, et al. (2014) Acute kidney injury in dogs with leptospirosis. Vet J 200(3): 472-478.

[17] Ross L. (2017) Acute kidney injury in dogs and cats. Vet Clin North Am Small Anim Pract 47(5): 1111-1126.

[18] Hokamp JA, Cianciolo RE. (2017) Urinary enzyme markers of acute kidney injury in dogs. Vet Clin Pathol 46(2): 197-205.

[19] Burr P, Egan B, Murphy J. (1985) Icterus in dogs with leptospirosis. Vet Rec 117(15): 384-385.

[20] Gamberale F, Dominguez M, Pellizzari O, et al. (2013) Coagulation abnormalities in dogs with leptospirosis. Vet Clin Pathol 42(4): 489-495.

[21] Schuller S, Francey T, Hartmann K, et al. (2015) European consensus statement on leptospirosis in dogs and cats. J Vet Intern Med 29(1): 102-113.

[22] Kohn B, Steinicke K, Arndt G, et al. (2010) Pulmonary abnormalities in dogs with leptospirosis. J Vet Intern Med 24(6): 1277-1282.

[23] Bowes MA, Haines DM, Swayne DE. (1995) Leptospiral pulmonary hemorrhage in dogs. Vet Pathol 32(4): 445-449.

[24] Townsend WM, Stiles J, Krohne SG. (2008) Leptospira-associated uveitis in dogs. Vet Ophthalmol 11(4): 265-268.

[25] Rentko VT, Clark N, Ross LA, Schelling SH. (1992) Canine leptospirosis: a retrospective study of 17 cases. J Vet Intern Med 6(4): 235-244.

[26] Turner LH. (1970) Leptospirosis. 3. Maintenance, isolation and demonstration of leptospires. Trans R Soc Trop Med Hyg 64(4): 623-641.

[27] Ellis WA. (1986) The diagnosis of leptospirosis in farm animals. In: The Present State of Leptospirosis Diagnosis and Control. Martinus Nijhoff: 13-31.

[28] Cole JR Jr, Sulzer CR, Pursell AR. (1973) Improved microtechnique for the leptospiral microscopic agglutination test. Appl Microbiol 25(6): 976-980.

[29] Barr SC, Lyman R, Fiske RA, et al. (1994) Use of the microscopic agglutination test for serodiagnosis of leptospirosis in dogs. J Vet Diagn Invest 6(4): 477-479.

[30] Moore GE, Guptill LF, Ward MP, et al. (2006) Performance of a commercial serologic test for detection of antibodies to Leptospira spp. in dogs. J Am Vet Med Assoc 229(11): 1765-1769.

[31] Martin AR, Armstrong D, Collin JR, et al. (2013) Duration of vaccine-induced immunity against leptospirosis in dogs. Vet Rec 173(11): 267.

[32] Niloofa R, Fernando N, de Silva NL, et al. (2015) Diagnosis of leptospirosis: comparison between microscopic agglutination test, IgM-ELISA, and IgM rapid immunochromatography. BMC Infect Dis 15: 442.

[33] Musso D, La Scola B. (2013) Laboratory diagnosis of leptospirosis: a challenge. J Microbiol Immunol Infect 46(4): 245-252.

[34] Haake DA, Chao G, Zuerner RL, et al. (2000) The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun 68(4): 2276-2285.

[35] Dey S, Mohan CM, Kumar P, et al. (2008) Recombinant LipL32 antigen for single serum dilution ELISA for detection of canine leptospirosis. Vet Microbiol 128(3-4): 380-386.

[36] Greene CE, Sykes JE, Moore GE, et al. (2013) Leptospirosis. In: Small Animal Internal Medicine, 5th ed. Elsevier: 1070-1081.

[37] Stoddard RA, Gee JE, Wilkins PP, et al. (2009) Detection of pathogenic Leptospira spp. through TaqMan real-time PCR targeting the LipL32 gene. Diagn Microbiol Infect Dis 64(3): 247-255.

[38] Ahmed A, Engelberts MF, Boer KR, et al. (2009) Development and validation of a real-time PCR for detection of pathogenic Leptospira species in clinical samples. PLoS One 4(9): e7093.

[39] Villumsen S, Pedersen R, Borenius S, et al. (2012) Comparison of real-time PCR and culture for diagnosis of leptospirosis in humans and dogs. Zoonoses Public Health 59(5): 371-379.

[40] Rojas P, Monahan AM, Schukken YH, et al. (2010) Detection of pathogenic leptospires in urine by real-time PCR. Vet Microbiol 141(1-2): 133-139.

[41] Wilson MR, Naccache SN, Samayoa E, et al. (2014) Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 370(25): 2408-2417.

[42] Hsieh PS, Tsai MT, Wu YC, et al. (2011) Combined use of serology and PCR for diagnosis of leptospirosis in dogs. Vet Rec 169(18): 464.

[43] Dahlem EG, Johnson ME, Schick AE, et al. (2019) Symmetric dimethylarginine as a marker for acute kidney injury in dogs with leptospirosis. J Vet Intern Med 33(4): 1690-1696.

[44] Klaasen HL, Molkenboer MJ, Vrijenhoek MP, et al. (2003) Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine. Vet Rec 153(9): 270-274.

[45] Bolin CA, Cassells JA. (1990) Isolation of Leptospira interrogans serovar bratislava from a dog. J Vet Diagn Invest 2(4): 337-338.

[46] Higa HH, Fujinami RS. (1989) Cross-reacting antigens of Leptospira. Rev Infect Dis 11(Suppl 4): S803-S808.

[47] Troedsson ME, Houser RA. (2011) Doxycycline for treatment of canine leptospirosis. J Am Vet Med Assoc 238(2): 203-208.

[48] Minke JM, Bey R, Tronel JP, et al. (2009) Use of penicillin G in acute leptospirosis in dogs. Vet Ther 10(1): E1-E8.

[49] Landers EA, Epstein SE, Jones SE, et al. (2014) Hemodialysis for acute kidney injury due to leptospirosis in dogs. J Vet Emerg Crit Care 24(5): 564-572.

[50] Major A, Schweighauser A, Francey T. (2014) Prognostic factors in canine leptospirosis: a retrospective study of 169 cases. J Vet Intern Med 28(6): 1783-1790.